Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT04615013

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

The purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy with concurren…

United States24 participantsStarted 2020-11-23

Treatment: Capecitabine, Carboplatin

All recent trials (12 shown)

Active — Not RecruitingPhase 2

NCT03784326

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastro…

To learn if atezolizumab in combination with oxaliplatin and 5-fluorouracil (5-FU), when given before surgery, can help to control esophageal and/or gastroesoph…

United States43 participantsStarted 2019-02-19

Treatment: Atezolizumab, Conventional Surgery

CompletedNot Applicable

NCT04183218

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

This trial studies cardiac changes after radiation or chemo-radiation for the treatment of lung or esophageal cancer that has not spread to other places in the…

United States24 participantsStarted 2019-09-23

Treatment: Biospecimen Collection, Cardiac Event Monitor

Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

All recent trials (12 shown)

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastro…

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

All recent trials (12 shown)

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastro…

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's E…

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophage…

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metast…

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Ga…

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesopha…

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemo…